Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Clinical trial NCT00397384 · COMPLETED

Trial details

NCT number: NCT00397384
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Adenocarcinoma of the Colon Adenocarcinoma of the Rectum Advanced Adult Primary Liver Cancer Carcinoma of the Appendix Gastrointestinal Stromal Tumor Metastatic Gastrointestinal Carcinoid Tumor Metastatic Squamous Neck Cancer With Occult Primary Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Recurrent Adult Primary Liver Cancer Recurrent Anal Cancer Recurrent Basal Cell Carcinoma of the Lip Recurrent Colon Cancer

Start date: 2007-01-01
Primary completion: 2013-06-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.